Home > PE Ratio > VAISHALI PHARMA

VAISHALI PHARMA
PE (Price/Earnings) Ratio

The Current P/E Ratio of VAISHALI PHARMA is 28.93.

Share Price ₹157.8Apr 26,2024
Market Cap ₹168.8 Cr
Earnings-TTM₹5.8 CrTTM-Standalone Results
Price/Earnings28.93xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for VAISHALI PHARMA
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of VAISHALI PHARMA

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of VAISHALI PHARMA is calculated as :

Current Market Cap [ ₹168.8 Cr] as on Apr 26,2024

(/) Earnings [ ₹5.8 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 28.93x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for VAISHALI PHARMA , the investors are currently willing to pay 28.93 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of VAISHALI PHARMA !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of VAISHALI PHARMA over the last five years.

Historical PE (Price/Earnings) ratio chart of VAISHALI PHARMA


PE Ratio Performance Analysis for VAISHALI PHARMA

- VAISHALI PHARMA 's latest p/e ratio is 28.93x.

- VAISHALI PHARMA 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 277.39x.

- VAISHALI PHARMA 's operated at median p/e ratio of 25.11x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, VAISHALI PHARMA 's p/e ratio peaked in Mar2020 at 1288.35x.

- VAISHALI PHARMA 's p/e ratio hit its five-year low in Mar2022 of 17.34x.


How does VAISHALI PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
VAISHALI PHARMA 5.8428.93168.8
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6340.11360,920.0
CIPLA LTD3,744.0330.39113,794.0
DR REDDYS LABORATORIES LTD5,209.4020.02104,316.0
ZYDUS LIFESCIENCES LTD2,954.2032.2995,380.9
DIVIS LABORATORIES LTD1,382.9777.27106,860.0
MANKIND PHARMA LTD1,743.3054.4294,869.4
TORRENT PHARMACEUTICALS LTD1,494.0060.9591,057.0
LUPIN LTD1,809.7440.6973,642.4
AUROBINDO PHARMA LTD2,777.8923.8666,278.5
ABBOTT INDIA LTD1,145.5847.9854,961.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs VAISHALI PHARMA 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 20.02x
Max industry PE 77.27x
Median industry PE 40.11x
Average industry PE 41.54x



You may also like the below Video Courses